Early research (Phase 1)Study completedNCT01158300
What this trial is testing
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 28